Trial Profile
Clinical Trials Insight: 700057156
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Jun 2010
Price :
$35
*
At a glance
- Drugs Tranilast (Primary)
- Indications Allergic conjunctivitis; Allergic rhinitis; Asthma; Atopic dermatitis; Gout; Hypertrophic scars; Hyperuricaemia; Keloids; Rheumatoid arthritis
- Focus Pharmacodynamics
- Sponsors Nuon Therapeutics
- 23 Jun 2010 Results presented at the European League Against Rheumatism (EULAR) 2010 Annual European Congress of Rheumatology, according to a Nuon Therapeutics media release.
- 23 Jun 2010 New trial record
- 04 Jun 2010 Results will be presented at the European League Against Rheumatism (EULAR) 2010 Annual European Congress of Rheumatology, according to a Nuon Therapeutics media release.